Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Neurooncol. 2019 Feb 22;142(3):479–487. doi: 10.1007/s11060-019-03119-w

Table 1:

Number of base pair effect per allele included in the analysis based on data by the ENGAGE Consortium.[13]

SNP Chromosome Gene Effect allele Base Pairs* EAF cases (%) EAF controls (%) Allelic OR 95%-CI P-value**

rs11125529 2 ACYP2 A 66.9 12.7 13.3 0.95 0.82–1.10 0.49

rs10936599 3 TERC C 117.3 24.4 22.2 1.14 1.01–1.28 0.02

rs7675998 4 NAF1 G 89.7 21.7 21.7 1.00 0.89–1.13 0.94

rs2736100 5 TERT C 94.2 52.3 49.0 1.13 1.03–1.25 0.01

rs9420907 10 OBFC1 C 82.8 16.7 14.1 1.22 1.07–1.39 0.003***

rs3027234 17 CTC1 C 25.2 21.7 22.3 0.97 0.86–1.08 0.55

rs8105767 19 ZNF208 G 57.6 30.4 28.7 1.08 0.97–1.20 0.15

rs755017 20 RTEL1 G 74.1 13.5 12.1 1.15 1.00–1.33 0.05

*

Number of base pairs the affected allele increases the genotypically-estimated leukocyte telomere length (LTL)[13, 32]

**

p-value for risk for meningioma under an additive frequentist model

***

Significant after correction for multiple testing (eight degrees of freedom).

Abbreviations: EAF: estimated allele frequency; bp: base pairs, OR: odds ratio, LTL: Leukocyte telomere length.